Literature DB >> 19364606

Nephrogenic systemic fibrosis.

Jeffrey C Weinreb1, Phillip H Kuo.   

Abstract

There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19364606     DOI： 10.1016/j.mric.2009.01.003

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN： 1064-9689            Impact factor:   2.266


  8 in total

1.  Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Authors:  Christopher Klenk; Rakhee Gawande; Vy Thao Tran; Jennifer Trinh Leung; Kevin Chi; Daniel Owen; Sandra Luna-Fineman; Kathleen M Sakamoto; Alex McMillan; Andy Quon; Heike E Daldrup-Link
Journal:  J Nucl Med       Date:  2015-10-15       Impact factor: 10.057

2.  Evaluation of the supraaortic arteries using non-contrast-enhanced Velocity MR angiography "Inhance".

Authors:  Nina Lummel; Tobias Boeckh-Behrens; Juergen Lutz; Michael Burke; Jennifer Linn
Journal:  Neuroradiology       Date:  2012-05-09       Impact factor: 2.804

3.  Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices.

Authors:  Khaled Abdel-Kader; Priti R Patel; Alexander J Kallen; Ronda L Sinkowitz-Cochran; Warren K Bolton; Mark L Unruh
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

4.  A 3D balanced-SSFP Dixon technique with group-encoded k-space segmentation for breath-held non-contrast-enhanced MR angiography.

Authors:  Manojkumar Saranathan; Ersin Bayram; Pauline W Worters; James F Glockner
Journal:  Magn Reson Imaging       Date:  2011-11-03       Impact factor: 2.546

Review 5.  Imaging for the prognosis of autosomal dominant polycystic kidney disease.

Authors:  Kyongtae T Bae; Jared J Grantham
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

6.  Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.

Authors:  Edit Dósa; Daniel J Guillaume; Marianne Haluska; Cynthia A Lacy; Bronwyn E Hamilton; Jeffrey M Njus; William D Rooney; Dale F Kraemer; Leslie L Muldoon; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2010-12-16       Impact factor: 12.300

7.  Renal artery stenosis: comparative assessment by unenhanced renal artery MRA versus contrast-enhanced MRA.

Authors:  Michael M Y Khoo; Dhafer Deeab; Wladyslaw M W Gedroyc; Neil Duncan; David Taube; Elizabeth A Dick
Journal:  Eur Radiol       Date:  2011-02-20       Impact factor: 5.315

8.  3D FIESTA pulse sequence for assessing renal artery stenosis: is it a reliable application in unenhanced magnetic resonance angiography?

Authors:  Caterina Gaudiano; Fiorenza Busato; Emiliana Ferramosca; Carlo Cecchelli; Beniamino Corcioni; Lucia Barbara De Sanctis; Antonio Santoro; Rita Golfieri
Journal:  Eur Radiol       Date:  2014-07-25       Impact factor: 5.315
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.